{"id":"W2888458270","doi":"10.1016/s0140-6736(18)31858-0","title":"Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial","year":2018,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":785,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Servier; Abbott Vascular; Regeneron Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; University of Bern; Amarin Corporation; Boston Scientific Corporation; Amgen; Pfizer; Biosensors International Group; Canada Research Chairs; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ticagrelor; Medicine; Aspirin; Clopidogrel; Percutaneous coronary intervention; Acute coronary syndrome; Coronary artery disease; Myocardial infarction; Internal medicine; Clinical endpoint; Cardiology; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04259067970504685,"score_gpt":0.324734246856156,"score_spread":0.2821435671511091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}